3-Hydroxyphencyclidine (3-HPC), a derivative of phencyclidine (PCP), is ever more attracting researcher focus due to sparse data suggesting unique pharmacological properties. Current studies demonstrate that 3-HPC may display distinct responses on the central system, possibly contributing to some of the unexpected symptoms linked with PCP exposure.